Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2005
04/28/2005WO2004101779A3 Functional characterization of myo-inositol monophosphatase
04/28/2005WO2004099379A3 Use of jag2 expression in diagnosis of plasma cell disorders
04/28/2005WO2004098634A3 Protein arginine n-methyltransferase 2 (prmt-2)
04/28/2005WO2004095216A3 The symmetry relationships between pairs of connectrons
04/28/2005WO2004088280A3 Method and apparatus for improved gas detection
04/28/2005WO2004086034A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor adenosine a3(adora3)
04/28/2005WO2004085049A3 Preparation and application of encoded bead aggregates in combinatorial chemistry
04/28/2005WO2004078775A3 Intracellular signaling-induced ret-independent gdnf receptor-effected morphological changes
04/28/2005WO2004072606B1 Polymeric membranes for use in electrochemical sensors
04/28/2005WO2004063707A3 Agglutination tests for detection of microorganisms
04/28/2005WO2004061416A3 Methods for attaching molecules
04/28/2005WO2004050833A3 Glyceraldehyde 3-phosphate dehydrogenase-s(gapds), a glycolytic enzyme expressed only in male germ cells,is a target for male contraception
04/28/2005WO2004049907A3 Compositions and methods for treating transplants
04/28/2005WO2004042355A3 Semipermeable membrane-based sampling systems
04/28/2005WO2004033631A8 Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using
04/28/2005WO2004032839A3 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors
04/28/2005WO2004032622A3 Production of peptides in plants as viral coat protein fusions
04/28/2005WO2004031913A8 Artificial intelligence for analyzing hypothetical models
04/28/2005WO2004020065A3 Microfluidic affinity system using polydimethylsiloxane and a surface modification process
04/28/2005WO2004008369A3 A decision criterion based on the responses of a trained model to additional exemplars of the classes
04/28/2005WO2004004666A3 Modulators of leukocyte activation, hck compositions and methods of use
04/28/2005WO2003104424A3 Novel molecular conjugates for signal amplification
04/28/2005WO2003100076A3 Pna probes, probe sets, method and kits pertaining to the determination of listeria
04/28/2005WO2003099201A3 Compositions and methods of use for a fibroblast growth factor
04/28/2005WO2003095971A3 Posh nucleic acids, polypeptides and related methods
04/28/2005WO2003093493A3 Pregnancy detection
04/28/2005WO2003092631A3 Cyclic peptide anti-viral agents and methods
04/28/2005WO2003073826A8 Novel compositions and methods for cancer
04/28/2005WO2003062792A3 Methods for determining drug responsiveness
04/28/2005WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
04/28/2005WO2002092768A3 Novel alanine transaminase enzyme and methods of use
04/28/2005WO2002072013A8 Method of treating malignancies through induction of blood immune responses
04/28/2005US20050091713 Nucleic acid nematicides
04/28/2005US20050091703 Nonhuman model animal of th2-mediated hyperimmune response
04/28/2005US20050090993 Computer code for portable sensing
04/28/2005US20050090992 Using multiple perturbations to elucidate connectivity in network systems
04/28/2005US20050090991 Novel method for predicting the spatial-arrangement topology of an amino acid sequence using free energy combined with secondary structural information
04/28/2005US20050090961 Agricultural product handling system
04/28/2005US20050090752 Method for evaluating and treating hypertension
04/28/2005US20050090751 Method and system for characterization and mapping of tissue lesions
04/28/2005US20050090658 Comprises polymorphic variations/point mutations linked to cation channel dysfunctions; genetic engineering; treansgenic animal; antibody
04/28/2005US20050090647 Pharmaceutical compositions for treating arthritis and inflammatory disease
04/28/2005US20050090558 Suppressing immune response in a mammal comprising accelerating lymphocyte homing (ALH) to any of mesenteric or peripheral lymph tissues or Peyer's patches by administering an ALH-immunosuppressive compound
04/28/2005US20050090471 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
04/28/2005US20050090441 inducing prolonged in vivo gene expression in mammal by contacting nonmuscular tissue with a nucleic acid, a histone, and an amphipathic compound; animal models:
04/28/2005US20050090434 Novel therapeutic targets in cancer
04/28/2005US20050090022 Cheaper, more accessible method for single parameter and multiparameter analysis of cell populations; target cell population is analyzed by preserving morphologic characteristics of cells for analysis
04/28/2005US20050090020 Use of deep-frozen blood or a preparation containing deep-frozen blood for biological test procedures for, or with, determination of the blood response on contact with the test material
04/28/2005US20050090018 Method and detector capture of gases
04/28/2005US20050090015 Functionalized particles for composite sensors
04/28/2005US20050090000 Novel human 7TM protein and polynucleotides encoding the same
04/28/2005US20050089994 Able to automatically sample volumic fractions of the dialysate contained in the peritoneum of the patient at specific time intervals in order to evaluate the peritoneal membrane characteristics and/or improve the peritoneal dialysis for the patient
04/28/2005US20050089966 Chemically modified enzymes with multiple charged variants
04/28/2005US20050089957 Chimera; immunoglobuins; antibodies; host cells; immunohistochemistry
04/28/2005US20050089951 Method for labeled amidation of biological molecule and method for analyzing biological molecule
04/28/2005US20050089949 Automated laser capture microdissection
04/28/2005US20050089948 Contains mucolytic agent (cysteine, glutathione, N-acetyl-cysteine, N-isobutyrylcysteine) and bactericide (sodium hydroxide, sodium citrate); centrifuging; reduces cross-contamination
04/28/2005US20050089945 Abeta 42 lowering agents
04/28/2005US20050089943 Wester blot immunoassay; bioassay; quantitative analysis; Creutzfeldt-Jacob disease
04/28/2005US20050089942 For detection of tuberculosis; kits
04/28/2005US20050089941 Drug screening; SCFV fragments; polyacrylamide gel electrophoresis
04/28/2005US20050089940 Measuring receptor homodimerization
04/28/2005US20050089939 Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
04/28/2005US20050089938 For treatment of epilepsy, hypertension, angina pectoris, cerebral ischaemia, Parkinson's disease, insulin-dependent diabetes, and/or Lambert-Eaton myasthenic syndrome
04/28/2005US20050089936 Such as 5-chloro-3-phenyl-1H-indole-2-carboxylic acid benzylamide; immobilization; drug screening
04/28/2005US20050089935 Combinatorial library of 3-aryl-1h-indole-2-carboxylic acid
04/28/2005US20050089932 Novel proteins with targeted binding
04/28/2005US20050089931 Libraries of cominatorial chemistry based on a thin film substrate by mixing a thiol (biospecific component) capable of displaying a binding partner to the target molecule (histidine) and an inert spacer thiol component in defined proportions to control the spacial density; drug design; high affinity
04/28/2005US20050089927 Novel peptides for the diagnosis of schizophrenia
04/28/2005US20050089924 Increasing the sensitivity of assays while decreasing the sample volume by integrating aluminum-coated reflective sidewalls mirrors into microchannels used in assays of fluorescently tagged molecules; increasing the signal-to-noise ratio of the optical signal using geometrical cross-section shapes
04/28/2005US20050089922 Inhibiting nucleic acid synthesis, comprising a nucleic acid inhibitor that is capable of binding or has affinity to an enzyme with polymerase activity; an oligonucliotide inhibiting or preventing nucleic acid synthesis, amplification or sequencing; polymerase inhibitors; viricides; HIV
04/28/2005US20050089919 In vitro method of measuring the expression level of the human gene for early lymphocyte activation antigen CD69 exon1 (CD69) in the biological sample and providing a diagnosis and an increased susceptibility if the expression level is increased and vice versa; accurate and safe intervention
04/28/2005US20050089918 In-situ cell extraction and assay method
04/28/2005US20050089912 Nucleic acids having polynucleotide sequences to encode two novel splice variant isoforms of nuclear factor kappa-B, subunit 1 (NFKB1) called NFKB1sv1 and NFKB1sv2; screening for agonist and antagonist ligands to bind to the new isoforms; antiinflammatory, - carcinogenic agents; AIDS;lupus; viricides
04/28/2005US20050089911 87 human secreted proteins
04/28/2005US20050089906 Haplotype estimation method
04/28/2005US20050089905 Polymorphisms associated with ion-channel disease
04/28/2005US20050089901 Complex of Raman-active reporter molecule, a binding molecule, and a surface enhancing particle capable of causing surface enhanced Raman scattering;
04/28/2005US20050089900 Method of managing and displaying gene expression data
04/28/2005US20050089896 Method to control tumor progression and invasiveness
04/28/2005US20050089894 Controller programmed for data processing; nucleic acid measurement and polymerase chain reaction module; extracting nucleic acids from cells; thermocycling; mass spectrometry
04/28/2005US20050089887 Novel human ion channel proteins
04/28/2005US20050089881 Superficial zone protein-binding molecules and uses thereof
04/28/2005US20050089880 Which have a SET domain, such deregulation being of importance in certain cancers; SET domains are protein methyltransferase enzymes
04/28/2005US20050089878 Determining a plurality of functional annotation scores for a query protein and comparing these functional annotation scores to distributions of similar functional annotation scores derived from a plurality of reference proteins
04/28/2005US20050089877 Robust genotyping method using DNA chip and DNA chip used therein
04/28/2005US20050089873 Creating peptide receptors using molecular imprinting and using quartz crystal microbalance (QCM) or a surface plasma resonance (SPR) equipped with a flow injection system to detect the peptide
04/28/2005US20050089868 Modulators of tissue regeneration
04/28/2005US20050089860 Oligonucleotide sequences free from mishybridization and method of designing the same
04/28/2005US20050089855 Expression vector comprising nucleotide sequences coding glycine transport protein for use in identifying modulator for treatment and prevention of nervous system and psychiatric disorders
04/28/2005US20050089847 Short chain dehydrogenases/reductases(sdr)
04/28/2005US20050089843 Polyclonal antibody specific for mannose-terminated viral envelope protein for use in detection and prevention of viral diseases
04/28/2005US20050089842 Method for photo-immobilizing and/or recovering a biomaterial
04/28/2005US20050089841 Induction of a Th1-like response in vitro
04/28/2005US20050089839 Assay
04/28/2005US20050089838 Method for identifying compounds that specifically deplete mast cells
04/28/2005US20050089525 Subunit respiratory syncytial virus vaccine preparation
04/28/2005US20050089518 Prospective identification and characterization of breast cancer stem cells
04/28/2005US20050089510 Immunization against plaque forming diseases such as cardiovascular disorders with vaccines for disaggregation
04/28/2005US20050089447 Base sequence detecting electrode, base sequence detecting device and base sequence detecting method